Laurent Pharmaceuticals receives Health Canada’s approval to initiate Covid-19 clinical trial

This article was originally published here

The trial, which is planned to start imminently in multiple hospitals in Canada, will enroll approximatively 200 hospitalized COVID-19 patients for a treatment duration of 14 days. «

The post Laurent Pharmaceuticals receives Health Canada’s approval to initiate Covid-19 clinical trial appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply